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Kaposiform hemangioendothelioma (KHE) is an uncommon vascular tumor that affects young children. It
frequently affects the trunk, limbs, head and face, but rarely the retroperitoneal area. This retrospective
study analyzed two cases of retroperitoneal KHE admitted to the Children’s Hospital of Fudan University,
and investigated the clinical characteristics and treatment of this disease.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Materials and methods
Two patients with combined retroperitoneal KHE and Kasabach-
Merritt phenomenon (KMP) were admitted to the Children’s
Hospital of Fudan University from 2009 to 2011.
2. Case 1
A ﬁve-month-old male child was admitted with a complaint of
an “accidentally discovered abdominal mass noticed a week ago.”
Physical examination revealed a distended, left mid-to upper
abdomen. Upon palpation, it was felt as a solid mass, 7 cm in
diameter, with a clear boundary and no tenderness. Ultrasonic
examination revealed a giant mass comprising a mixture of solid
and liquid contents in the adrenal area of upper left retro-
peritoneum, indicating the possibility of neuroblastoma. The mass
was located adjacent to the tailof pancreas and left kidney, resulting
in the compression and deformation of the spleen. Abdominal
enhanced CT scan revealed a huge mass with a clear boundary and
measuring 7.4  7.7  10 cm in size, located in the left abdomen,
exceeding the midline. The mass appeared as isodense to slightly
hypodense lesions with stripe calciﬁcation. The lesions exhibited
heterogeneous enhancement, while the spleen was not clearly
visualized. Computed tomography angiography (angiography or: þ86 21 64931901.
Inc. This is an open access article uCTA) showed that the blood supply of the mass originated from the
branch of splenic artery (Fig. 1A). Complete blood count (CBC)
revealed a platelet count of 27  109/L. Pre-operative diagnosis was
“retroperitoneal mass with the possibility of neuroblastoma.”
After platelet transfusions, exploratory laparotomy and mass
biopsy were performed. During the operation, a giant solid tumor
was found originating in the retroperitonium, which elevated the
spleen and pancreas. Nodular projection was detected on the sur-
face of the mass. The mass inﬁltrated the spleen, and could not be
separated. Due to the unique pathological manifestation, no precise,
short-term diagnosis was possible. After two weeks of consultation
with the Pathological Department of Fudan University Shanghai
Cancer Center, we ﬁnally diagnosed the tumor as (abdominal)
Kaposiform hemangioendothelioma, based on biopsy.3. Case 2
A four-month-old female child was diagnosed as volvulus based
on “darkened feces accompanied with crying and vomiting” at
a local hospital. During exploratory laparotomy, hemorrhagic
enteritis was diagnosed and the child did not receive any special
treatment. After postoperative hormone therapy and platelet
transfusions, symptoms were relieved within a short period
followed by recurrence. Physical examination revealed a pale
appearance and a soft and distended abdomen. No tenderness
or apparent solid mass was detected. The bowel sound was weak.
CBC showed a hemoglobin value of 70 g/L; platelet count,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A: Disease onset. A huge heterogenous mass with a clear boundary and a diameter of 7 cm, located in the left abdomen, exceeding the midline; stripe calciﬁcation can be seen.
The lesions exhibited heterogeneous enhancement, while the spleen was not clearly visualized. B: One year after VCR treatment. The mass was diminished in size. Spleen was
restored to normal position. C: Two years after VCR treatment. The tumor almost disappeared, with only slight calciﬁcation left.
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positive for fecal occult blood. Ultrasonic scan indicated abnormal
bowel in the left abdomen. MRI revealed an abnormal crumby
signal in the mesentery root. The intestine wall was thickened and
swollen accompanied with a large amount of ascites (Fig. 2A).
CTA revealed multiple abnormal enhancements in the head of
pancreas and mesentery root. Intestine wall became thickened and
swollen accompanied with a large amount of ascites and collateral
vessel formation (Fig. 2B).
After consultation with multiple clinical departments, the child
was diagnosed as retroperitoneal KHE combined with thrombocy-
topenia. Medical hemorrhagic diseases and strangulated intestinal
obstruction were both excluded.4. Results
4.1. Case 1
Due to the unique pathological manifestations, we ﬁnally
certiﬁed the pathological results as retroperitoneal KHE after
multidisciplinary consultation 2 weeks later. The child underwent
experimental chemotherapy with cyclophosphamide (CTX),adriamycin and etoposide (VP16) on day 5, postoperatively.
Persistent thrombocytopenia following chemotherapy and
methylprednisolone pulse therapy was used to arrive at a deﬁnitive
pathological diagnosis. After the treatment, platelet counts were
rapidly elevated to 121  109/L. Oral drugs (5 mg/kg, qd) was then
administered instead of intravenous methylprednisolone and
platelet counts were maintained at 100  109/L. The tumor size was
reduced by 25%, 1 month later. During the treatment phase, platelet
counts decreased to 69  109/L prompting reduction of the dose of
methylprednisolone and gradual substitution with vincristine
(VCR) treatment comprising 10 cycles. The tumor almost dis-
appeared although slight calciﬁcation was visible 2 years later
(Fig. 1B and C).4.2. Case 2
After consultationwithmultiple clinical departments, a deﬁnitive
diagnosis of retroperitoneal KHE was obtained. The child received
hormonal pulse therapy without any response. The child exhibited
continuous bleeding and non-elevated platelet counts. VCRwas used
simultaneously and platelet counts were elevated immediately to
85  109/L, resulting in gradual hemostasis. After 4 cycles of VCR
Fig. 2. A: MRI revealed abnormal crumby signals in the mesentery root, and intestine wall became thick and swollen accompanied with a large amount of ascites. B: CTA revealed
multiple abnormal enhancements in the head of pancreas and mesentery root. Intestine wall became thickened and swollen accompanied with a large amount of ascites and
collateral vessel formation. C: MRI revealed disappearance of previous abnormal crumby signals, with only slight intestinal wall enhancement.
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hormone therapywasgradually discontinued. The childwasprovided
ordinary food and showed no hemafecia. All chemotherapies were
completed, hormone therapy discontinued and the child’s nutritional
status recovered rapidly. Follow-up MRI revealed disappearance of
previous abnormal crumby signals, with only slight enhancement of
intestinal wall (Fig. 2C).
5. Discussion
The morbidity of retroperitoneal KHE is relatively low. Since
2001, only nine reports of retroperitoneal KHE have been published
in pediatric surgery journals worldwide [1e9], though other cases
maybe reported in other specialties Due to the low incidence of this
disease, therapeutic experience is limited and misdiagnosis is
common. Pathological manifestations may contribute to correct
diagnosis. However, considering the lack of expertise, the limited
vigilance of physicians, and inadequate multidisciplinary consul-
tation, accurate diagnosis is not easy. In this retrospective study, the
two cases of retroperitoneal KHE provide valuable insights for
clinical diagnosis. 1) Both surface and retroperitoneal KHE usually
occur in children, especially in 2e4-month-old infants, and
commonly accompanied with thrombocytopenia. Thrombocyto-
penia was detected during the early stage of disease onset in two
children. Physicians administered repeated platelet transfusions,
leading to temporal elevation of platelet and subsequent severeplatelet reduction. 2) The differential diagnosis of retroperitoneal
KHE [2,4] includes retroperitoneal solid tumors such as neuro-
blastoma, primitive neuroectodermal tumors (PNET) and other
hematologic tumors, such as lymphoma, idiopathic thrombocyto-
penic purpura (ITP). Among the 2 children mentioned above, one
was misdiagnosed as neuroblastoma and received anti-
neuroblastoma chemotherapy brieﬂy. The other case was mis-
diagnosed as volvulus and received exploratory laparotomy for
digestive tract bleeding. Therefore, the deﬁnitive diagnosis of KHE
is quiet difﬁcult. 3) Based on experience with our 2 case studies in
treating KHE, other than marked thrombocytopenia, medical im-
aging showed extensively vascularized, retroperitoneal regular or
irregular mass. The microscopic examination revealed ﬂake-like,
continuous small nodular or lobular tumors separated by ﬁbrous
tissue. The tumor was composed of many small proliferative ves-
sels, spindle-shaped and epithelioid endothelial cells, which
resembled Kaposi sarcoma [10]. The pathological examination
revealed glomerulus-like structure but was negative for GLUTl. The
pathological manifestations of KHE varied and clinical experience
was essential for a correct diagnosis. 4) Knowledge and therapeutic
experience are crucial for the diagnosis of KHE. In the present study,
one case did not manifest the typical pathology of KHE. However,
our therapy resulted in good outcomes. Therefore, careful obser-
vation, comprehensive judgment, bold hypothesis, multidisci-
plinary consultation and discussion are important factors for
accurate diagnosis.
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outcomesof retroperitonealKHEvaried.Highdoseof hormonepulse
therapy, low dose of VCR pulse chemotherapy or administration of
interferon have been used for the treatment of retroperitoneal KHE
[11e13]. Our treatment experience was as follows: 1) The two cases
responded to early stage of hormone therapy, with partial relief.
Nevertheless, the two cases showed tolerance or resistance to hor-
mone therapy during the early or late stage of therapy. Finally, pa-
tients were administered intravenous injection of low-dose VCR to
stabilize their condition. The tumor completely vanished two years
after disease onset in one case. In the other case, after 4 cycles of VCR
treatment, the platelet counts were elevated from 4  109/L to
154  109/L. Symptoms like hemafecia, abdominal distension and
vomitingwere diminished. Among different therapies for combined
KHE and KMP (body trunks, limbs, head, face, and retroperitoneal
area) in children, hormone pulse therapy was efﬁcient in 60% of
children. The efﬁciency of VCR therapy was as high as 90% for those
resistant tohormonepulse therapy. Further, short-termVCR therapy
was associated with few side-effects and quicker cessation of hor-
mone therapy. VCR has been proposed by a few researchers as the
ﬁrst-line treatment for combined KHE and KMP instead of hor-
mones. 2) During the course of therapy in children with combined
KHE and KMP, platelet transfusion should be carried out based on
indications. Vasogenic proteins were released by platelet degranu-
lation, which may induce the growth of Kaposi-like hemangioen-
dothelioma, accelerating platelet damage, and leading to severe
platelet reduction [14]. On the other hand, the half-life of platelets is
1e24 h. The transfused platelets were depleted in a short period of
time, resulting in limited effect on elevation of platelet counts [15].
Therefore, in children with combined KHE and KMP, platelet trans-
fusion should be performed with caution unless obvious sponta-
neous bleeding occurs. Individualized therapy is recommended for
the treatment of combined KHE and KMP, whereas standardized
protocal should also be considered.
We retrospectively analyzed the clinical characteristics, diag-
nosis and treatment regimens of two cases of retroperitoneal KHE.
We would like to share our experiences with other physicians
interested in the management of the non-malignant vascular tu-
mor. Additional cases and therapeutic experiences may result
beneﬁt children with retroperitoneal KHE.References
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